인쇄하기
취소
|
The Zemiglo license case which has been postponed by the debate over submission of marketing data might get accelerated.
On the 26th, the Seoul Central District Court Civil Case Division 17 conducted the 8th defense for the damage suit filed by Sanofi Aventis against LG Chem(former LG Life Sciences) and Daewoong Pharmaceutical regarding Zemiglo license.
Taking only a short time, the 8th defen...